DST Capital LLC - 17 Jun 2021 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role: 10%+ Owner
Signature: /s/ Chad Porter, by power of attorney
Issuer symbol: BSTG
Transactions as of: 17 Jun 2021
Transactions value $: $300,000
Form type: 4
Filing time: 21 Jun 2021, 19:30:35 UTC
Next filing: 09 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSTG	Common Stock	Purchase	$300,000	+150,000	+5%	$2	3,150,000	17 Jun 2021	Direct	F1
holding	BSTG	Common Stock						30,722	17 Jun 2021	Owned by sole member of reporting person

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSTG	Warrant (right to buy)	Purchase		+75,000			75,000	17 Jun 2021	Common Stock	75,000	$2	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 17, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 150,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 75,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $300,000.

Content

On June 17, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 150,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 75,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $300,000.